Medical specialists from Sweden tagged as investigators in clinical trials studying Ovarian Neoplasms

Total 35 results

Anders Rosenmüller, MD
Seen in:
- Västervik, Department of Obstetrics and Gynecology, Västervik Hospital
Trials:
- NCT05284552 (Principal Investigator)
Conditions:
- Epithelial Ovarian Cancer
Anke Zbikowski, MD
Seen in:
- Jönköping, Department of Obstetrics and Gynecology, Ryhov County Hospital
Trials:
- NCT05284552 (Sub-Investigator)
Conditions:
- Epithelial Ovarian Cancer
Annika Holmquist, MD, PhD
Seen in:
- Linköping, Department of Oncology, Linköping University Hospital
Trials:
- NCT05284552 (Sub-Investigator)
Conditions:
- Epithelial Ovarian Cancer
Boglarka Fekete, MD
Seen in:
- Gothenburg, Department of Oncology, Sahlgrenska University Hospital
Trials:
- NCT05284552 (Sub-Investigator)
Conditions:
- Epithelial Ovarian Cancer
Catarina Notelid Claus, MD
Seen in:
- Eksjö, Department of Obstetrics and Gynecology, Highland Hospital
Trials:
- NCT05284552 (Sub-Investigator)
Conditions:
- Epithelial Ovarian Cancer
Charlotte Öfverman, MD, PhD
Seen in:
- Umeå, Department of Obstetrics and Gynaecology, Norrland University Hospital
Trials:
- NCT05284552 (Sub-Investigator)
Conditions:
- Epithelial Ovarian Cancer
Charlotte Palmqvist, MD, PhD
Seen in:
- Gothenburg, Sahlgrenska University Hospital and Sahlgrenska Academy
Trials:
- NCT06298877 (Principal Investigator)
Conditions:
- Ovarian Cancer
Christiane Sackbrook, MD
Seen in:
- Jönköping, Department of Obstetrics and Gynecology, Ryhov County Hospital
Trials:
- NCT05284552 (Sub-Investigator)
Conditions:
- Epithelial Ovarian Cancer
Daniel Hunde, MD
Seen in:
- Solna, Stockholm, Karolinska University Hospital
Trials:
- NCT06298877 (Sub-Investigator)
Conditions:
- Ovarian Cancer
Gabriel Lindahl, MD, PhD
Seen in:
- Linköping, Department of Oncology, Linköping University Hospital
Trials:
- NCT05284552 (Principal Investigator)
Conditions:
- Epithelial Ovarian Cancer
Hanna Reimerson, MD
Seen in:
- Eksjö, Department of Obstetrics and Gynecology, Highland Hospital
Trials:
- NCT05284552 (Sub-Investigator)
Conditions:
- Epithelial Ovarian Cancer
Helena Avenström, MD
Seen in:
- Västervik, Department of Obstetrics and Gynecology, Västervik Hospital
Trials:
- NCT05284552 (Sub-Investigator)
Conditions:
- Epithelial Ovarian Cancer
Jeffrey Yachnin
Seen in:
- Other, Stockholm, Karolinska University Hospital
- Stockholm, Flemingsberg, Karolinska Comprehensive Cancer Center - Studieenheten
- Stockholm, GSK Investigational Site
- Stockholm, Karolinska University Hospital
Trials:
- NCT05195008 (Principal Investigator)
- NCT04526509 (Principal Investigator)
- NCT05229900 (Principal Investigator)
- NCT05287945 (Principal Investigator)
Conditions:
Johannes Matthias Löhr, Professor
Seen in:
- Stockholm, Karolinska University Hospital Huddinge
Trials:
- NCT05172310 (Sub-Investigator)
Conditions:
Karin Bergmark, MD, PhD
Seen in:
- Gothenburg, Department of Oncology, Sahlgrenska University Hospital
Trials:
- NCT05284552 (Principal Investigator)
Conditions:
- Epithelial Ovarian Cancer
Laila Falknäs, MD
Seen in:
- Jönköping, Department of Obstetrics and Gynecology, Ryhov County Hospital
Trials:
- NCT05284552 (Principal Investigator)
Conditions:
- Epithelial Ovarian Cancer
Madelene Wedin, MD, PhD
Seen in:
- Linköping, Linköping University Hospital
Trials:
- NCT06298877 (Principal Investigator)
Conditions:
- Ovarian Cancer
Magnus Nilsson, Professor
Seen in:
- Stockholm, Department of Radiation Physics and Nuclear Medicine, Karolinska University Hospital
- Stockholm, Karolinska University Hospital Huddinge
Trials:
- NCT05619016 (Sub-Investigator)
- NCT05172310 (Sub-Investigator)
Conditions:
Malena Tiefenthal Thrane, MD
Seen in:
- Eksjö, Department of Obstetrics and Gynecology, Highland Hospital
Trials:
- NCT05284552 (Principal Investigator)
Conditions:
- Epithelial Ovarian Cancer
Marta Lomnytska
Seen in:
- Uppsala, Alice Bjoernlund-Larsen
Trials:
- NCT03772028 (Principal Investigator)
Conditions:
- Ovarian Cancer
Mihaela Asp, MD, PhD
Seen in:
- Lund, Skåne University Hospital
Trials:
- NCT06298877 (Principal Investigator)
Conditions:
- Ovarian Cancer
Narmin Rasul, MD
Seen in:
- Jönköping, Department of Obstetrics and Gynecology, Ryhov County Hospital
Trials:
- NCT05284552 (Sub-Investigator)
Conditions:
- Epithelial Ovarian Cancer
Oscar Derke, MD
Seen in:
- Linköping, Department of Oncology, Linköping University Hospital
Trials:
- NCT05284552 (Sub-Investigator)
Conditions:
- Epithelial Ovarian Cancer
Päivi Kannisto, MD, Ass Prof
Seen in:
- Lund, Skåne University Hospital
Trials:
- NCT06298877 (Sub-Investigator)
Conditions:
- Ovarian Cancer
Pernilla Dahm-Kähler, MD, PhD
Seen in:
- Gothenburg, Department of Oncology, Sahlgrenska University Hospital
- Gothenburg, Sahlgrenska University Hospital and Sahlgrenska Academy
Trials:
- NCT05284552 (Sub-Investigator)
- NCT06298877 (Principal Investigator)
Conditions:
- Epithelial Ovarian Cancer;
- Ovarian Cancer
Pernilla Israelsson, MD, PhD
Seen in:
- Umeå, Department of Obstetrics and Gynaecology, Norrland University Hospital
Trials:
- NCT05284552 (Sub-Investigator)
Conditions:
- Epithelial Ovarian Cancer
Rimma Axelsson, Professor
Seen in:
- Stockholm, Department of Radiation Physics and Nuclear Medicine, Karolinska University Hospital
- Stockholm, Karolinska University Hospital Huddinge
Trials:
- NCT05619016 (Principal Investigator)
- NCT05172310 (Principal Investigator)
Conditions:
Sahar Salehi, MD, Ass Prof
Seen in:
- Solna, Stockholm, Karolinska University Hospital
Trials:
- NCT06298877 (Principal Investigator)
Conditions:
- Ovarian Cancer
Shefqet Halili, MD
Seen in:
- Värnamo, Department of Obstetrics and Gynecology, Värnamo Hospital
Trials:
- NCT05284552 (Principal Investigator)
Conditions:
- Epithelial Ovarian Cancer

Clinical Trials on Ovarian Neoplasms

Roswell Park Cancer Institute

Completed

Intravital Microscopy in Evaluating Patients With Primary Peritoneal, Fallopian Tube, or Stage IA-IV Ovarian Cancer

Fallopian Tube Carcinoma | Primary Peritoneal Carcinoma | Stage IIA Ovarian Cancer | Stage IIB Ovarian Cancer | Stage IIC Ovarian Cancer | Stage IIIA Ovarian Cancer | Stage IIIB Ovarian Cancer | Stage IIIC Ovarian Cancer | Stage IV Ovarian Cancer | Stage IA Ovarian Cancer | Stage IB Ovarian Cancer | Stage IC... and other conditions

United States
Barbara Ann Karmanos Cancer Institute
National Cancer Institute (NCI)

Completed

Folate Receptor in Diagnosing Ovarian Cancer Using Serum Samples From Patients With Newly Diagnosed Pelvic Mass or Previously Diagnosed Ovarian Cancer

Recurrent Ovarian Carcinoma | Ovarian Neoplasm | Ovarian Clear Cell Tumor | Adnexal Mass | Ovarian Endometrioid Tumor | Ovarian Serous Tumor | Borderline Ovarian Epithelial Tumor

United States
Maastricht University Medical Center
VieCuri Medical Centre; Orbis Medical Centre; St.Jans Gasthuis Weert; Laurentius...

Terminated

Study Into a New Diagnostic Tool (Simple Ultrasound-based Rules) in Patients With Adnexal Masses (SUBSONiC)

Ovarian Cancer | Ovarian Carcinoma | Ovarian Cyst | Ovarian Mass

Netherlands
Health Science Center of Xi'an Jiaotong University

Recruiting

Efficacy and Safety of Involving Field Radiotherapy in the Oligo-lesions(Metastasis/Recurrent/Refractory) of Ovarian Cancer

Ovarian Cancer | Cancer of the Ovary | Ovarian Neoplasm | Ovary Cancer | Neoplasms, Ovarian | Ovary Neoplasms | Ovary Neoplasm | Cancer of Ovary | Cancer, Ovarian | Ovarian Cancers | Neoplasm, Ovarian | Neoplasm, Ovary | Neoplasms, Ovary | Cancer, Ovarian Stromal | Cancers, Ovary | Ovary Cancers | Cancers, Ovarian

China
Centre Leon Berard
Cancer Côte d'or registry; Cancer Calvados registry

Unknown

Optimisation of Disease Management in Patients With Epithelial Ovarian Cancer in France (Ovaire01)

Ovarian Epithelial Cancer

France
University of Washington
National Cancer Institute (NCI)

Completed

Taking Care of Her Program in Patients With Stage III or IV Ovarian Cancer and Spouse Caregivers

Caregiver | Stage IIIA Ovarian Cancer | Stage IIIB Ovarian Cancer | Stage IIIC Ovarian Cancer | Stage IV Ovarian Cancer

United States
Massachusetts General Hospital
Johns Hopkins University; M.D. Anderson Cancer Center; National Cancer Institute... and other collaborators

Recruiting

Developing a Test for the Detection of Ovarian Cancer

Ovarian Neoplasms | Fallopian Tube Neoplasms | Stage III Ovarian Cancer AJCC v8 | Stage IIIA Ovarian Cancer AJCC v8 | Stage IIIA1 Ovarian Cancer AJCC v8 | Stage IIIA2 Ovarian Cancer AJCC v8 | Stage IIIB Ovarian Cancer AJCC v8 | Stage IIIC Ovarian Cancer AJCC v8 | Stage IV Ovarian Cancer AJCC v8 | Stage... and other conditions

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Completed

Survivorship Care Planning in Improving Quality of Life in Survivors of Ovarian Cancer

Cancer Survivor | Stage IIIA Ovarian Epithelial Cancer | Stage IIIB Ovarian Epithelial Cancer | Stage IIIC Ovarian Epithelial Cancer | Stage IIA Ovarian Epithelial Cancer | Stage IIB Ovarian Epithelial Cancer | Stage IIC Ovarian Epithelial Cancer | Stage IA Ovarian Epithelial Cancer | Stage IB Ovarian... and other conditions

United States
GlaxoSmithKline

Completed

Combination Study Of SB-485232 (Interleukin 18) And Doxil For Advanced Stage Epithelial Ovarian Cancer

Neoplasms, Ovarian

United States
Seoul National University Hospital
Samsung Medical Center; Takeda; Asan Medical Center; Yonsei University

Not yet recruiting

PARP Inhibitor Oral Maintenance in Low-Risk Ovarian Cancer (POLO)

Ovarian Cancer | Epithelial Ovarian Cancer | Ovarian Cancer Stage IV | Ovarian Cancer Stage III

Medical specialists from Sweden tagged as investigators in clinical trials studying Ovarian Neoplasms

Clinical Trials on Ovarian Neoplasms

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malaysia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations